Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01107860 · ClinicalTrials.gov registry record
Cone Beam Computed Tomography for Breast Imaging
A clinical trial of Breast Cancer, sponsored by Koning Corporation.
- Completed
- Registry status
- 401
- Enrollment target
- 1
- Study location
NCT01107860: Completed study of Breast Cancer, sponsored by Koning Corporation.
NCT01107860 is a study of Breast Cancer that has completed, run by Koning Corporation. The registered enrollment target is 401 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01107860, a study of Breast Cancer, has completed, sponsored by Koning Corporation.
- COMPLETED
- Registry status
- 401 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of this study is to continue the investigation of cone beam computed tomography (CBCT) for breast imaging already underway in the diagnostic setting by providing a compelling body of evidence incorporating non-contrast CBCT in the study protocol. The goal is to accumulate a body of evidence to provide data to incorporate CBCT into the diagnostic work-up of breast lesions.
Conditions Studied
Interventions
- DEVICE Computed Tomography
Study Locations (1)
New York
- Elizabeth Wende Breast Care - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 401 participants |
| Start Date | 2010-01 |
| Est. Completion | 2013-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01107860
The ClinicalTrials.gov registry entry for NCT01107860 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 401 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (86% lower). The listed sponsor is Koning Corporation, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Computed Tomography is the first listed.
NCT01107860 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01107860 about?
NCT01107860 is a clinical study titled "Cone Beam Computed Tomography for Breast Imaging". The primary aim of this study is to continue the investigation of cone beam computed tomography (CBCT) for breast imaging already underway in the diagnostic setting by providing a compelling body of evidence incorporating non-contrast CBCT in the study protocol. The goal is to accumulate a body of e...
What is the current status of trial NCT01107860?
This trial is currently completed. The enrollment target is 401 participants. The study started on 2010-01. Estimated completion is 2013-06.
What conditions does trial NCT01107860 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT01107860?
The interventions under investigation include: Computed Tomography (DEVICE).
Who is sponsoring clinical trial NCT01107860?
This trial is sponsored by Koning Corporation, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01107860 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.